Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer
暂无分享,去创建一个
J. Herman | K. Schuebel | S. Baylin | E. Gabrielson | N. Ahuja | Wei Zhang | Jana Jeschke | H. O’Hagan | M. Calmon | M. Dhir | C. Hooker | Hsing-Chen Tsai | P. Rahal | Kornel E. Schuebel | E. Pappou | T. Fu | C. Siebenkäs | Alexander Herrera | J. Jeschke
[1] Ying Zhuo,et al. The role of NEFL in cell growth and invasion in head and neck squamous cell carcinoma cell lines. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[2] Mahmoud Abbas,et al. Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response , 2014, Cancer medicine.
[3] Gianluca Bontempi,et al. A comprehensive overview of Infinium HumanMethylation450 data processing , 2013, Briefings Bioinform..
[4] S. Powers,et al. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. , 2013, Gastroenterology.
[5] R. Grimer,et al. Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma , 2013, Epigenetics.
[6] Ludmila V. Danilova,et al. Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines , 2013, Clinical Cancer Research.
[7] H. Putter,et al. Chromatin remodeling of human subtelomeres and TERRA promoters upon cellular senescence , 2013, Epigenetics.
[8] Pau Farré,et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array , 2013, Epigenetics & Chromatin.
[9] L. Cope,et al. Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen , 2012, Epigenetics.
[10] Xiao-Qing Li,et al. NEFL mRNA Expression Level Is a Prognostic Factor for Early-Stage Breast Cancer Patients , 2012, PloS one.
[11] S. Baylin,et al. DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes , 2012, Nucleic acids research.
[12] Martin J. Aryee,et al. A DNA hypermethylation module for the stem/progenitor cell signature of cancer , 2011, Genome research.
[13] C. Sotiriou,et al. Evaluation of the Infinium Methylation 450K technology. , 2011, Epigenomics.
[14] Peng Huang,et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. , 2011, Cancer research.
[15] Peter A. Jones,et al. A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.
[16] C. Ricketts,et al. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. , 2011, Cancer research.
[17] Fang Fang,et al. Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis , 2011, Science Translational Medicine.
[18] J. Herman,et al. Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer , 2011, Clinical Cancer Research.
[19] M. Fraga,et al. DNA methylation epigenotypes in breast cancer molecular subtypes , 2010, Breast Cancer Research.
[20] Martina Wiedau-Pazos,et al. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. , 2010, Human molecular genetics.
[21] Juna Lee,et al. Neurofilament Heavy Polypeptide Regulates the Akt-β-Catenin Pathway in Human Esophageal Squamous Cell Carcinoma , 2010, PloS one.
[22] J. Herman,et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. , 2009, Cancer research.
[23] E. Vardar,et al. beta-catenin gene mutation in invasive ductal breast cancer. , 2008, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[24] Gangning Liang,et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line , 2008, Proceedings of the National Academy of Sciences.
[25] T. Giordano,et al. Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast , 2008, Clinical Cancer Research.
[26] J. Herman,et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. , 2008, Cancer research.
[27] T. Mikkelsen,et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.
[28] Wei Chen,et al. Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer , 2007, PLoS genetics.
[29] S. Baylin,et al. Stem Cell Chromatin Patterns: An Instructive Mechanism for DNA Hypermethylation? , 2007, Cell cycle.
[30] Zohar Yakhini,et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.
[31] Kelly M. McGarvey,et al. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.
[32] A. Petzold. Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss , 2005, Journal of the Neurological Sciences.
[33] S. Limborska,et al. Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND) , 2004, European Journal of Human Genetics.
[34] J. Slingerland,et al. Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression , 2003, Cell cycle.
[35] J. Herman,et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. , 2003, Cancer cell.
[36] J. Herman,et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. , 2002, Cancer research.
[37] O. Evgrafov,et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.
[38] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[39] W. Recant,et al. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer , 1996, Genes, chromosomes & cancer.
[40] Y. Nakamura,et al. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. , 1992, Cancer research.
[41] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[42] P M Steinert,et al. Molecular and cellular biology of intermediate filaments. , 1988, Annual review of biochemistry.
[43] J W Griffin,et al. Control of axonal caliber by neurofilament transport , 1984, The Journal of cell biology.
[44] M. Shelanski,et al. Intermediate filaments in nervous tissues , 1978, The Journal of cell biology.
[45] R. Friede,et al. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice , 1970, The Anatomical record.